Allie Casey

Articles

Affordable Care Act Positively Affects Stage at Diagnosis

May 18th 2017

More Stage I cancers were diagnosed after the passage of the Affordable Care Act within five screenable disease types than were diagnosed before ACA implementation.

Clarifying the Role of Oncology Nurse Navigators

April 1st 2017

Tricia Strusowski, MS, RN, discusses the role of the oncology nurse navigator and how these staffers can help meet outcome and quality standards set by the CMS's OCM.

Federal Healthcare Policy Is Front and Center at CANCERSCAPE Conference

March 31st 2017

While at the annual CANCERSCAPE meeting of ACCC, Kavita Patel, MD, MS, comments on uncertainy in the healthcare environment and key policy to be aware of.

Addressing Sexuality and Fertility Issues in Breast Cancer Patients

March 25th 2017

Leslie Schover, PhD, discusses strategies to help patients with breast cancer who have sexuality and fertility issues.

Sexual Health Counseling Should Be Paired With AI Breast Cancer Treatment

March 15th 2017

Preventive sexual counseling can be effective in reducing sexual dysfunction resulting from the treatment of breast cancer patients with aromatase inhibitors; however, that intervention should be provided early in treatment and supported by encouragement from providers.

RCCA Widens Range with Connecticut Partnership

January 20th 2017

Regional Cancer Care Associates has continued its expansion along the East Coast by adding 2 Connecticut-based cancer centers with 6 cancer specialists to its network of independent practices.

Post-Mastectomy Radiation Associated With Increased Complications for Some Patients

December 22nd 2016

Patients with breast cancer who received radiation therapy after undergoing a mastectomy reported increased complications and lower satisfaction.

Axillary Lymph Node Dissection Can Be Avoided for Some Patients With Breast Cancer, Study Shows

December 19th 2016

Results of a clinical trial show that an axillary lymph node dissection can be avoided for patients with large, operable tumors in the breast, no clinical signs of cancer in the axillary nodes before being treated with neoadjuvant chemotherapy, and no signs of cancer following a sentinel lymph node biopsy during surgery.

High-User Focus Trims Oncology Tab

December 13th 2016

It was 15 years ago that Jeffrey Brenner, MD, hypothesized that patients with the highest costs in the Camden, New Jersey, healthcare system received the worst care.

Checkpoint Inhibitors Show Promise in Glioblastoma

November 19th 2016

Findings from the phase II trials KEYNOTE-028 of pembrolizumab and MEDI4736 (durvalumab) point to a role for checkpoint inhibitors in the treatment of glioblastoma multiforme, based on encouraging efficacy signals and safety data with the two agents.

Expert Discusses Next Steps With Immunotherapy in Lung Cancer

November 15th 2016

Hossein Borghaei, DO, discuss what lies ahead for immunotherapy in lung cancer, and what changes may be on the horizon for such agents as pembrolizumab (Keytruda), nivolumab (Opdivo), and ipilimumab (Yervoy) in the frontline setting.

Anti-Nausea Benefit Observed With Olanzapine in Patients Receiving HEC Regimen

September 26th 2016

For patients receiving highly emetogenic chemotherapy, olanzapine (Zyprexa) was found to demonstrate a significant improvement in the prevention of nausea when it was added to a standard antiemetic regimen.

Support for Advanced Practice Providers

September 25th 2016

The Community Oncology Alliance has recognized a need within the APP community and responded by creating the COA Advanced Practice Provider Network, with the hope that its tools will enable APPs to review important practice issues and discuss solutions among themselves.

Obesity an Increasing Incidence in Breast Cancer, CRC Survivors

September 3rd 2016

Obesity is more prevalent in cancer survivors, specifically in those with a history of breast or colorectal cancer, compared with those without any history of disease.

Study Calls for Interventions to Increase Colorectal Cancer Screening in Hispanic Men

August 28th 2016

Colorectal cancer mortality rates have been on the decline in California for both men and women since the mid-1990s, but for one group—Hispanic men—rates have remained essentially unchanged, and a new study suggests that lower rates of screening may be the chief driver of this disparity.